Epidemiological characteristics and therapeutic advances of EGFR exon 20 insertion mutations in non‐small cell lung cancer

Epidemiological characteristics and therapeutic advances of EGFR exon 20 insertion mutations in non‐small cell lung cancer

Abstract The third most prevalent type of epidermal growth factor receptor (EGFR) mutation, EGFR exon 20 insertions (EGFRex20ins), involves 2%–12% of all cases of EGFR‐positive non‐small cell lung cancer (NSCLC). Approximately 90% of the mutations occur within the loop structure region, and the most...

Full description

Bibliographic Details
Main Authors: Binyang Pan, Jiaqi Liang, Haochun Shi, Kungeng Rao, Weigang Guo, Cheng Zhan
Format: Article
Language:English
Published: Wiley 2023-11-01
Series:Thoracic Cancer
Subjects:
EGFR exon 20 insertions
epidemiology
non‐small lung cancer
targeted therapy
Online Access:https://doi.org/10.1111/1759-7714.15127

Internet

https://doi.org/10.1111/1759-7714.15127

Similar Items